Research Article

Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes

Table 1

Clinical characteristics and serum PGRN levels of study subjects.

NC SDM Microangiopathies

122955
Age (years) 54.58 ± 9.5658.86 ± 12.6860.76 ± 8.78
Sex (male/female) 7/518/1132/23
Duration of diabetes (years) 01.77 ± 1.009.57 ± 4.80
SBP (mmHg) 112.50 ± 10.31127.93 ± 14.24141.67 ± 21.30
DBP (mmHg) 68.33 ± 7.9076.21 ± 6.6481.89 ± 12.44
BMI (kg/m2) 20.97 ± 1.4124.26 ± 2.0424.75 ± 1.84
WHR 0.84 ± 0.050.88 ± 0.050.90 ± 0.05
HbA1c (%) 4.93 ± 0.4210.20 ± 2.059.47 ± 2.12
FPG (mmol/L) 4.53 ± 0.4810.47 ± 2.5810.47 ± 3.03
Lg(FINS) (mU/L) 1.11 ± 0.121.27 ± 0.071.19 ± 0.09
Lg(HOMA-IR) 0.42 ± 0.140.93 ± 0.130.84 ± 0.14
TG (mmol/L) 1.40 ± 0.283.99 ± 1.544.09 ± 1.72
TC (mmol/L) 3.81 ± 0.515.21 ± 1.095.15 ± 1.20
HDL-c (mmol/L) 1.22 ± 0.120.96 ± 0.120.99 ± 0.12
LDL-c (mmol/L) 2.22 ± 0.253.57 ± 0.793.80 ± 1.08
UAER (mg/24 h)24.55 ± 4.8625.82 ± 3.99359.53 ± 174.55
BUN (mmol/L) 5.17 ± 0.805.23 ± 1.178.25 ± 3.09
CRE (μmol/L) 66.75 ± 5.7271.48 ± 12.37131.61 ± 73.33
eGFR (mL/min/1.73 m2)109.27 ± 19.46102.85 ± 25.3261.19 ± 28.50
WBC (×109/L) 5.58 ± 0.995.82 ± 0.996.87 ± 1.61
IL-6 (ng/L)8.03 ± 2.1713.73 ± 4.3820.14 ± 5.97
TNF-α (μg/L)10.74 ± 1.1512.57 ± 3.2919.56 ± 5.39
PGRN (μg/L) 45.21 ± 4.7547.18 ± 4.5171.54 ± 27.56
ACEI or ARB, (%)0 (0%)2 (6.90%)19 (34.55%)
Oral antidiabetics, (%)0 (0%)27 (93.10%)42 (76.36%)
Insulin, (%)0 (0%)4 (13.79%)32 (58.18%)

Data are presented as means ± SD. SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; WHR: waist-to-hip ratio; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; FINS: fasting serum insulin; HOMA-IR: Homeostasis Model Assessment for Insulin Resistance; TG: triglyceride; TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; UAER: urinary albumin excretion rate; BUN: blood urea nitrogen; CRE: creatinine; eGFR: estimated glomerular filtration rate; WBC: white blood cell; IL-6: interleukin-6; TNF-α: tumor necrosis factor alpha; PGRN: progranulin; ACEI: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blocker.
NC: normal control; SDM: simple diabetes mellitus.
Compared with NC, , . Compared with SDM, , .